🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate the safety and efficacy of a lo...
Status
Completed
Location
North Central Neurology Associates, PC
Start Date
2011-03
Trial ID
NCT01328379
Treatments Being Tested
This study evaluates the effects of sustained-release oral dalfampridine in...
Status
Unknown
Location
Multiple Sclerosis Center
Start Date
2014-11
Trial ID
NCT02259361
Treatments Being Tested
Cognitive impairment is common in multiple sclerosis (MS) and has devastati...
Status
Completed
Location
Buffalo General Hospital
Start Date
2011-12
Trial ID
NCT02006160
Treatments Being Tested
The goal of this interventional double blind, randomized placebo controlled...
Status
Completed
Location
Multiple Locations
Start Date
2011-07-13
Trial ID
NCT05859802
Treatments Being Tested
To assess the safety and efficacy of 10 milligram (mg) twice a day (b.i.d.)...
Status
Completed
Location
University of Alabama
Start Date
2005-05
Trial ID
NCT00127530
Treatments Being Tested
The primary objective is to determine whether prolonged-release fampridine ...
Status
Completed
Location
Research site
Start Date
2014-09
Trial ID
NCT02219932
Treatments Being Tested
This randomized, double-blind, controlled, outpatient two-period, two-treat...
Status
Completed
Location
UCLA Department of Neurology
Start Date
2016-01
Trial ID
NCT02562066
Treatments Being Tested
Proof-of-concept study on the effects of 10 mg fampridine (oral administrat...
Status
Withdrawn
Location
University of Basel, Transfaculty Research Platform
Start Date
2040-01-01
Trial ID
NCT04516603
Treatments Being Tested
Many patients suffer from traumatic burns and current treatments do not inc...
Status
Recruiting
Location
University of Arizona
Start Date
2026-01-01
Trial ID
NCT06596434
Treatments Being Tested
This is a multicenter study conducted in 3 parts. Part A is a double-blind ...
Status
Completed
Location
Research Site
Start Date
2013-08
Trial ID
NCT01917019
Treatments Being Tested